FANTASTEC Breaks Cover with We Are Colony Acquisition
Fantastec Sports Technology Ltd (Fantastec) Managing Partner Steve Madincea confirmed today the company’s acquisition of We Are Colony Ltd (Colony), an award-winning OTT VOD technology company.
This is the first acquisition by Fantastec, a new sports industry innovator utilising emerging technologies to develop products, platforms and experiences which enable globally distanced fans to better connect and engage more deeply with the sports, teams and athletes they love. Fantastec was founded in 2017 by Madincea, an international sport’s industry entrepreneur.
“We moved quickly with our investment group on Colony because they have the three vital ingredients we look for in any acquisition: industry leading technology, an inspired and capable leadership team, and an ethos of continuous growth and constant innovation which aligns with Fantastec’s ambitions,” Madincea stated.
Colony CEO Sarah Tierney- whose previous roles include Founder of BAFTA-winning television production company Clarity Productions and Head of Content at global ed-tech VOD platform Twig - becomes COO of the Fantastec group.
Tierney commented: “In the face of enormous disruption across the film industry, we built Colony to empower content owners to easily reach engaged audiences around the world. Over the coming years, the sports industry will face similar levels of disruption from a globalising fan base along with rapidly changing tastes, demographics and habits. I am incredibly excited to join the Fantastec family and apply our advanced technology and comprehensive in-market experience to solving a range of challenges and opportunities in the sports sector.”
Madincea stated: “In our quest to use industry leading technologies to better serve the worldwide sport’s fan base we discovered the amazing Colony product and team. It was obvious the OTT VOD technology developed at Colony is an industry leader and has served them well in their prior work in the worldwide movie industry. Fantastec will now utilise these bespoke technologies in several new platforms and products to reach worldwide audiences for all sports. What our first Fantastec acquisition means in practical terms is we can agree terms with any sport, team or athlete and have them up and running on a proven global OTT VOD platform very quickly. We feel this makes for a powerful offering as the rights holder defines the terms not the channel. The purchase of Colony aligns with our Fantastec future fan vision to make engaging with sports more impactful via trailblazing technology”.
NOTES FOR EDITORS:
Fantastec is a unique blend of scientists, engineers, data analysts, designers, researchers, sports marketing creatives and communication professionals inventing the future of international fan engagement.
Utilising new and emerging technologies such as OTT VOD, VR / AR, wearable tech, AI and the Blockchain our mission is to enable globally distanced fans to engage more deeply with the sports, teams and athletes they love.
Steve Madincea is a recognised international sports industry entrepreneur having created, built and led sports sponsorship teams around the world to serve blue chip clients such as Aston Martin, Ford, Coca-Cola, Rolex, Subway, Casio, Samsung, PUMA, Jaguar, AT&T, Bridgestone, Red Bull, Land Rover, Shell, the NFL, the NBA, The UEFA Champions League, Formula 1 and The FIFA World Cup amongst others. Madincea ultimately bundled these disparate worldwide business units together and sold them prior to starting Fantastec.
Global OTT VOD streaming platform Colony was built to empower content owners to reach and engage audiences around the world. Colony's award-winning, end-to-end technology comprises an innovative isomorphic web application framework, video architecture and full back office suite. Colony launched in public beta in Spring 2015, working with film licensors across the world, and attracted registered users in 130 countries.
Colony was founded in 2013 by multi-format content strategy, production and distribution expert, and experienced media entrepreneur, Sarah Tierney. Colony was venture-backed by Archer Gray, Firestartr, The London Co-Investment Fund, Essex Innovation (GV Advisors), Seedcamp and international Angel investors.
Colony’s awards and recognitions include: The 2016 Everline Future 50, the 2016 and 2017 Start-ups 100, The British Small Business Awards, The Drum’s DADI Awards, The Screen Awards, The Drum Online Media Awards, The Digital Entrepreneur Awards and BIMA’s Hot 100 in 2014, 2016 and 2017.
FOR MORE INSIGHTS:
Visit our web-site (www.fantastec.io)
Fantastec Sports Technology Ltd.
Steve Madincea, Managing Partner
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
AURAK Gains SACSCOC Accreditation15.12.2018 13:49 | Tiedote
The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41 | Tiedote
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00 | Tiedote
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42 | Tiedote
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00 | Tiedote
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07 | Tiedote
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme